Ortin Global Profit & Loss Annual

BSE: 539287 | NSE: ORTINGLOBE | ISIN: INE749B01020 | Sector: Biotechnology & Drugs
11.84 +0.55 (4.87%)Updated : 16 May 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 2.116.028.238.17
Total Revenue 2.116.028.238.17
Costof Revenue Total 3.723.394.653.95
Gross Profit -1.602.633.584.22
Selling/ General/ Admin Expenses Total 0.560.850.951.05
Depreciation/ Amortization 0.230.250.290.29
Unusual Expense( Income) 0.000.03--
Other Operating Expenses Total 4.371.262.251.92
Total Operating Expense 8.885.788.147.21
Operating Income -6.770.240.090.96
Interest Inc( Exp) Net- Non- Op Total -0.48-0.38-0.81-0.87
Other Net 0.170.020.190.05
Net Income Before Taxes -7.08-0.11-0.530.14
Provisionfor Income Taxes 0.97-0.02-0.13-0.81
Net Income After Taxes -8.04-0.09-0.400.95
Net Income Before Extra Items -8.04-0.09-0.400.95
Net Income -8.04-0.09-0.400.95
Income Availableto Com Excl Extra Ord -8.04-0.09-0.400.95
Income Availableto Com Incl Extra Ord -8.04-0.09-0.400.95
Diluted Net Income -8.04-0.09-0.400.95
Diluted Weighted Average Shares 0.810.810.810.81
Diluted EPS Excluding Extra Ord Items -9.89-0.12-0.491.16
Diluted Normalized EPS -9.89-0.09-0.491.16
period Length 12.0012.0012.0012.00
period Type ----
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,381.00+25.85(1.10%)
2,353.15+22.90(0.98%)
435.60+3.15(0.73%)
1,814.35-52.45 (-2.81%)
1,659.75-36.30 (-2.14%)